Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 6/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.41 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31027151 | 1.00 | DYRK1A (0.58) | DYRK1AMEN1KMT2AHSD17B10KDM4E | |
| SCHEMBL7441456 | 0.96 | KDM4E (0.60) | DYRK1AMEN1KMT2AHSD17B10KDM4E | |
| SCHEMBL4287798 | 0.89 | KDM4E (0.50) | DYRK1AMEN1KMT2AHSD17B10KDM4E | |
| SCHEMBL30451928 | 0.89 | KDM4E (0.50) | DYRK1AMEN1KMT2AHSD17B10KDM4E | |
| SCHEMBL23537356 | 0.82 | PARP1 (0.59) | DYRK1AMEN1KMT2AHSD17B10KDM4E | |
| SCHEMBL29824193 | 0.82 | PARP1 (0.59) | DYRK1AMEN1KMT2AHSD17B10KDM4E | |
| SCHEMBL29824409 | 0.79 | PARP1 (0.64) | DYRK1AMEN1KMT2AHSD17B10KDM4E | |
| SCHEMBL8455896 | 0.79 | KDM4E (0.47) | MEN1KMT2AHSD17B10KDM4EALDH1A1 | |
| SCHEMBL23537328 | 0.79 | PARP1 (0.64) | DYRK1AMEN1KMT2AHSD17B10KDM4E | |
| SCHEMBL619090 | 0.78 | KDR (0.60) | MEN1KMT2AHSD17B10KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107235891-B | Preparation method of 4-bromocarbazole | 北京八亿时空液晶科技股份有限公司 | 2020-02-21 | — | — | CN | claimed |
| EP-1756057-B1 | PROCESS FOR THE PREPARATION OF CARVEDILOL | CIPLA LTD (IN) | 2010-08-04 | — | — | EP | claimed |
| US-7705163-B2 | Process for the preparation of carvedilol | CIPLA LIMITED (IN) | 2010-04-27 | — | — | US | claimed |
| US-20080234492-A1 | Process for the Preparation of Carvedilol | CIPLA LIMITED (IN) | 2008-09-25 | — | — | US | claimed |
| EP-1756057-A1 | PROCESS FOR THE PREPARATION OF CARVEDILOL | Cipla Ltd. (IN) | 2007-02-28 | — | — | EP | claimed |
| US-6977304-B2 | Method for producing indoles | MERCK PATENT GMBH (DE) | 2005-12-20 | — | — | US | claimed |
| WO-2005113502-A1 | PROCESS FOR THE PREPARATION OF CARVEDILOL | CIPLA LIMITED (IN) | 2005-12-01 | — | — | WO | claimed |
| EP-0023592-B1 | PROCESS FOR PREPARING 4-HYDROXYCARBAZOLE | Roche Diagnostics GmbH (DE) | 1983-03-30 | — | — | EP | claimed |
| US-4273711-A | Process for the preparation of 4-hydroxycarbazole | BOEHRINGER MANNHEIM GMBH (DE) | 1981-06-16 | — | — | US | claimed |
| EP-0023592-A1 | Process for preparing 4-hydroxycarbazole | Roche Diagnostics GmbH (DE) | 1981-02-11 | — | — | EP | claimed |
| US-20250381198-A1 | MIDAZOLAM AND KETAMINE FOR ENHANCED SEDATION | FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT | 2025-12-18 | — | — | US | disclosed |
| US-12350242-B2 | Binge behavior regulators | Clearmind Medicine Inc. (CA) | 2025-07-08 | — | — | US | disclosed |
| WO-2025110008-A1 | CURABLE COMPOSITION, METHOD FOR PRODUCING PIXEL, FILM, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND PHOTOPOLYMERIZATION INITIATOR | 富士フイルム株式会社 | 2025-05-30 | — | — | WO | disclosed |
| WO-2025094724-A1 | CURABLE COMPOSITION, METHOD FOR PRODUCING PIXEL, FILM, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND PHOTOPOLYMERIZATION INITIATOR | 富士フイルム株式会社 | 2025-05-08 | — | — | WO | disclosed |
| US-20250066667-A1 | Nonlinear Optical Chromophores Having Tetrahydrocarbazole Donor Groups, Lyotropic Compositions Containing the Same, and Methods of Poling Such Compositions | LIGHTWAVE LOGIC, INC. (US) | 2025-02-27 | — | — | US | disclosed |
| US-4273711-A | Process for the preparation of 4-hydroxycarbazole | BOEHRINGER MANNHEIM GMBH (DE) | 1981-06-16 | — | — | US | disclosed |
| EP-0023592-A1 | Process for preparing 4-hydroxycarbazole | Roche Diagnostics GmbH (DE) | 1981-02-11 | — | — | EP | disclosed |
| EP-0023592-A1 | Process for preparing 4-hydroxycarbazole | Roche Diagnostics GmbH (DE) | 1981-02-11 | — | — | EP | disclosed |
| US-3892766-A | Process for the preparation of 4-keto-1,2,3,4-tetrahydrocarbazole | WARNER LAMBERT CO | 1975-07-01 | — | — | US | disclosed |
| US-3892766-A | Process for the preparation of 4-keto-1,2,3,4-tetrahydrocarbazole | WARNER LAMBERT CO | 1975-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12350242-B2 | Binge behavior regulators | GABRB3, GABRB2, GABRB1 | DYRK1A 2022/4885MEN1 4592/4885KMT2A 501/4885 |
| US-20250381198-A1 | MIDAZOLAM AND KETAMINE FOR ENHANCED SEDATION | KCNA3, OPRK1, KCNA7 | DYRK1A 4470/4885MEN1 3968/4885KMT2A 489/4885 |
| US-20080234492-A1 | Process for the Preparation of Carvedilol | ADRB2, ADRB3, ADRB1 | DYRK1A 1066/4885MEN1 4640/4885KMT2A 1579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.